TrialThe Lancet. Oncology2024

LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001): results from arm 1 of a non-randomised, single-centre, phase 1/2 study.

Benjamin L Musher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.